文献速递神经US

低强度脉冲超声在帕金森病中的研究进展

Research Progress of Low-Intensity Pulsed Ultrasound in Parkinson's Disease.
PubMed 文献 · Ultrasound Med Biol · 2026-10-21

本文综述低强度脉冲超声(LIPUS)治疗帕金森病(PD)的研究现状。LIPUS利用低能量机械波发挥非热调节作用,机制涉及调节机械敏感离子通道、增强神经营养因子表达等。初步临床研究显示可改善运动与认知功能,但尚缺乏统一的最佳刺激参数共识。

要点

  • LIPUS为低能量机械波(通常<3 W/cm²),无组织破坏性热效应。
  • 初步临床研究提示可改善PD患者运动及认知功能。
  • 目前尚无统一的最佳刺激参数与靶向策略共识。

核心结论

  • LIPUS是具有疾病修饰潜力的无创神经调控技术,安全性较HIFU更优。
  • 现有证据提示LIPUS对PD运动与认知功能有改善作用,但循证级别有限。

研究设计与样本

  • 本文为叙述性综述,综合当前LIPUS治疗PD的声学参数、生物学机制与临床研究。
  • 未报告系统检索策略、纳入文献数量或证据质量分级方法。

诊断标准与关键数值

  • LIPUS强度通常低于3 W/cm²,区别于依赖热消融的HIFU。
  • LIPUS不需MRI热监控,具有可逆性,且不破坏靶核团(如Vim、STN)。

临床应用与阅片要点

  • LIPUS通过调节机械敏感离子通道(如Piezo1)和增强BDNF相关神经可塑性产生效应。
  • LIPUS还可促进自噬并调节小胶质细胞表型以减轻神经炎症。
  • 可穿戴LIPUS设备已用于初步临床研究,提示有临床应用前景。
  • 目前不宜将LIPUS作为PD常规治疗,应关注后续标准化临床试验结果。

局限性

  • LIPUS最佳刺激参数与靶向策略尚无统一共识。
  • 缺乏大规模标准化临床试验确立精确治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Parkinson's disease (PD) is a progressive neurodegenerative disorder where current pharmacological and surgical interventions, including Deep Brain Stimulation, often fail to reverse neuronal degeneration or halt disease progression. Low-intensity pulsed ultrasound (LIPUS) has emerged as a novel, non-invasive neuromodulation technology with significant therapeutic potential. This review synthesizes current research on the key acoustic parameters, biological mechanisms, and clinical applications of LIPUS in PD. Unlike High-Intensity Focused Ultrasound (HIFU), which relies on thermal ablation to destroy target nuclei (e.g., Vim, STN), LIPUS utilizes low-energy mechanical waves (typically <3 W/cm²) to exert non-thermal regulatory effects without damaging tissue. Mechanisms of action include the modulation of mechanosensitive ion channels (e.g., Piezo1), enhancement of neuroplasticity via brain-derived neurotrophic factor (BDNF), promotion of autophagy, and regulation of microglial phenotypes to reduce neuroinflammation. We further compare LIPUS with HIFU, highlighting the superiority of LIPUS regarding safety, reversibility, and the absence of requirement for MRI-based thermal monitoring. While preliminary clinical studies using wearable LIPUS devices indicate improvements in motor and cognitive functions, a unified consensus on optimal stimulation parameters and targeting strategies is lacking. Future research should focus on large-scale, standardized clinical trials to establish precise protocols for LIPUS as a disease-modifying therapy for PD.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Peng, Yang, Wang, et al. Research Progress of Low-Intensity Pulsed Ultrasound in Parkinson's Disease. Ultrasound Med Biol. 2026. PMID: 42907270. doi:10.1016/j.ultrasmedbio.2026.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。